Cognition Therapeutics, Inc. (CGTX) NASDAQ

1.74

-0.05579996(-3.10%)

Updated at December 04 03:24PM

Currency In USD

Valuation

Market Cap27.86M
Enterprise Value3.67M
P/E Ratio-3.4
PEG Ratio-0.36
Price/Sales Ratio518.02
Price/Book Ratio15.95
Enterprise/Revenue476.75
Enterprise/EBITDA-2.63

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-131.97
Operating Margin-211.76

Management Effectiveness

Return On Assets-1.68
Return On Equity-2.51

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-33.68M
Net Income-33.97M
Diluted EPS-0.85

Balance Sheet

Total Cash39.82M
Total Cash/Share0.17
Total Debt380,000
Total Debt/Equity0.06
Current Ratio1.54
Book Value Per Share0.11

Price History

52-Week Change363.16
52-Week High3.83
52-Week Low0.22
Moving Average 50 Days1.62
Moving Average 200 Days0.98

Statistics

Average Volume2.01M
Shares Outstanding73.58M
% Held by Institutions33.39

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A